by Stem Cell Network | Dec 29, 2010
Earlier this month, the Honourable Tony Clement, Minister of Industry, announced the establishment of the Centre for the Commercialization of Regenerative Medicine (CCRM) with a $15 million initial investment. The CCRM will be based in Toronto and is one of five new...
by Ubaka Ogbogu | Dec 16, 2010
President Obama’s Commission on the Study of Bioethical Issues today released a report of its ethical investigation and recommendations for oversight of the emerging field of synthetic biology. The report responds to a charge to the Commission issued by the President...
by Chris Kamel | Dec 9, 2010
Induced pluripotent stem (iPS) cells are generally created by the expression of a small number of key genes to reprogram adult cells into an undifferentiated, pluripotent state. Because some of the transcription factors used for reprogramming are oncogenes, as well as...
by Stem Cell Network | Dec 1, 2010
Of all the projects we run out of our small admin office, certainly one of the more visually compelling is the Cells I See art contest. As a side event at the Network’s scientific meeting, Cells I See usually elicits a great deal of buzz, as conference attendees...
by Chris Kamel | Nov 20, 2010
Because of some vocal opposition, stem cell research is no stranger to controversy. Usually this comes in the form of protests or government lobbying, but Nature News is reporting the story of a group that is trying to discredit the scientists themselves. The...
by Chris Kamel | Nov 7, 2010
Though methods to convert adult cells into induced pluripotent stem (iPS) cells continue to improve, transition from the lab bench to the clinic can be a trickier proposition. Due to imperfect efficiency, each manipulation — conversion of adult cell to iPS cell...
Comments